Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

Question 2

How does BMS-641988 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer progresses while I'm in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer clinical trial (NCT00326586). Contact the study team or your healthcare provider for specific answers.

What this study is about